T. Rowe Price Associates
LEGN icon

T. Rowe Price Associates’s Legend Biotech LEGN Stock Holding History

T. Rowe Price Associates’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-800,220
Closed -$28.4M – 3085
2025
Q2 		$28.4M Sell
800,220
-5,929,559
-88% -$192M ﹤0.01% 881
2025
Q1 		$228M Sell
6,729,779
-78,302
-1% -$2.81M 0.03% 395
2024
Q4 		$222M Sell
6,808,081
-4,357,503
-39% -$180M 0.03% 405
2024
Q3 		$544M Sell
11,165,584
-323,691
-3% -$17.2M 0.06% 265
2024
Q2 		$509M Buy
11,489,275
+540,155
+5% +$24.9M 0.06% 260
2024
Q1 		$614M Buy
10,949,120
+140,904
+1% +$8.5M 0.08% 242
2023
Q4 		$650M Buy
10,808,216
+1,114,848
+12% +$70.6M 0.09% 215
2023
Q3 		$651M Buy
9,693,368
+662,044
+7% +$46M 0.1% 208
2023
Q2 		$623M Buy
9,031,324
+7,939,175
+727% +$519M 0.09% 220
2023
Q1 		$52.7M Buy
1,092,149
+437,630
+67% +$21.4M 0.01% 674
2022
Q4 		$32.7M Sell
654,519
-1,279
-0.2% -$62K 0.01% 776
2022
Q3 		$26.8M Buy
655,798
+88,643
+16% +$4.16M ﹤0.01% 826
2022
Q2 		$31.2M Buy
+567,155
New +$24M ﹤0.01% 1036
2021
Q2 		– Sell
-124,229
Closed -$3.6M – 2941
2021
Q1 		$3.6M Sell
124,229
-455,548
-79% -$12.4M ﹤0.01% 1546
2020
Q4 		$16.3M Sell
579,777
-5,731
-1% -$165K ﹤0.01% 1268
2020
Q3 		$18.1M Sell
585,508
-263,509
-31% -$8.87M ﹤0.01% 1177
2020
Q2 		$36.1M Buy
+849,017
New +$33.2M ﹤0.01% 963

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

T. Rowe Price Associates's LEGN Position: Q3 2025 in Review

T. Rowe Price Associates sold out of Legend Biotech (LEGN) in Q3 2025, closing a stake of 800,220 shares — an estimated $28.4M sold.

T. Rowe Price Associates first reported a position in LEGN in Q2 2020 and held it in 17 quarters. The position peaked at $651M in Q3 2023. 199 funds tracked by Wall St. Rank hold LEGN as of Q3 2025.

  • T. Rowe Price Associates reported no remaining Legend Biotech position as of Q3 2025 after selling out during the quarter.
  • T. Rowe Price Associates sold 800,220 Legend Biotech shares in Q3 2025, an estimated $28.4M.
  • T. Rowe Price Associates first reported a position in Legend Biotech in Q2 2020 and held it in 17 quarters.
  • T. Rowe Price Associates's Legend Biotech position peaked at $651M in Q3 2023.
  • 199 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2025.

Based on T. Rowe Price Associates's 13F filing for Q3 2025, filed 14 Nov 2025.